Coagulation monitoring: Current techniques and clinical use of viscoelastic point-of-care coagulation devices

Anesthesia and Analgesia

Volumn 106, Issue 5, 2008, Pages 1366-1375

  Ganter, Michael T ^a   Hofer, Christoph K ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TRIEMLI HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; ANTICOAGULANT AGENT; APROTININ; CLOPIDOGREL; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TIROFIBAN; TRANEXAMIC ACID; ANTITHROMBOCYTIC AGENT; COAGULATING AGENT;

ANALYZER; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD SAMPLING; DEVICE; DRUG MECHANISM; FIBRINOLYSIS; HEART SURGERY; HEMOPHILIA; HUMAN; LIVER SURGERY; MEDICAL INSTRUMENTATION; POINT OF CARE TESTING; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY; THROMBOSIS; VISCOELASTICITY; ABDOMINAL SURGERY; BLOOD; BLOOD CLOTTING TEST; BLOOD RHEOLOGY; DRUG EFFECT; DRUG MONITORING; ELASTICITY; EQUIPMENT DESIGN; HEALTH CARE QUALITY; HOSPITAL INFORMATION SYSTEM; INSTRUMENTATION; LIVER; METHODOLOGY; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PREDICTION AND FORECASTING; REPRODUCIBILITY; STANDARD; THROMBOPHILIA; VISCOSITY;

ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; BLOOD LOSS, SURGICAL; CARDIAC SURGICAL PROCEDURES; COAGULANTS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DRUG MONITORING; ELASTICITY; EQUIPMENT DESIGN; HEMORHEOLOGY; HUMANS; LIVER; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; POINT-OF-CARE SYSTEMS; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE OF TESTS; QUALITY OF HEALTH CARE; REPRODUCIBILITY OF RESULTS; THROMBELASTOGRAPHY; THROMBOPHILIA; THROMBOSIS; VISCOSITY;

EID: 42449112966     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318168b367     Document Type: Article

References (80)

1. Ferraris VA, Ferraris SP, Saha SP, Hessel EA, Haan CK, Royston BD, Bridges CR, Higgins RS, Despotis G, Brown JR, Spiess BD, Shore-Lesserson L, Stafford-Smith M, Mazer CD, nett-Guerrero E, Hill SE, Body S. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007;83:S27-S86
2. Kozek-Langenecker S. Management of massive operative blood loss. Minerva Anestesiol 2007;73:401-15
3. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005;27:81-90
4. Hett DA, Walker D, Pilkington SN, Smith DC. Sonoclot analysis. Br J Anaesth 1995;75:771-6
5. Hartert H. Blutgerinnungstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wochenschrift 1948;26:557-83
6. Lang T, Bauters A, Braun SL, Potzsch B, von Pape KW, Kolde HJ, Lakner M. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005;16:301-10
7. Mallett SV, Cox DJ. Thrombelastography. Br J Anaesth 1992;69:307-13
8. Di Benedetto P, Baciarello M, Cabetti L, Martucci M, Chiaschi A, Bertini L. Thrombelastography. Present and future perspectives in clinical practice. Minerva Anestesiol 2003;69:501-9
9. Spiel AO, Mayr FB, Firbas C, Quehenberger P, Jilma B. Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. J Thromb Haemost 2006;4:411-6
10. Kettner SC, Panzer OP, Kozek SA, Seibt FA, Stoiser B, Kofler J, Locker GJ, Zimpfer M. Use of abciximab-modified thrombelastography in patients undergoing cardiac surgery. Anesth Analg 1999;89:580-4
11. Coakley M, Reddy K, Mackie I, Mallett S. Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J Cardiothorac Vasc Anesth 2006; 20:548-53
12. Hiippala ST. Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagul Fibrinolysis 1995;6:743-6
13. Nielsen VG. A comparison of the thrombelastograph and the ROTEM. Blood Coagul Fibrinolysis 2007;18:247-52
14. von Kaulla KN, Ostendorf P, von KE. The impedance machine: a new bedside coagulation recording device. J Med 1975;6:73-88
15. Dalbert S, Ganter MT, Furrer L, Klaghofer R, Zollinger A, Hofer CK. Effects of heparin, haemodilution and aprotinin on kaolin-based activated clotting time: in vitro comparison of two different point of care devices. Acta Anaesthesiol Scand 2006;50:461-8
16. Ganter MT, Dalbert S, Graves K, Klaghofer R, Zollinger A, Hofer CK. Monitoring activated clotting time for combined heparin and aprotinin application: an in vitro evaluation of a new aprotinin-insensitive test using SONOCLOT. Anesth Analg 2005;101:308-14
17. Ganter MT, Monn A, Tavakoli R, Genoni M, Klaghofer R, Furrer L, Honegger H, Hofer CK. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot. Eur J Cardiothorac Surg 2006;30:278-84
18. Ganter MT, Monn A, Tavakoli R, Klaghofer R, Zollinger A, Hofer CK. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2007;21:524-8
19. Tanaka KA, Szlam F, Sun HY, Taketomi T, Levy JH. Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin. Anesth Analg 2007;105:933-9
20. Tucci MA, Ganter MT, Hamiel CR, Klaghofer R, Zollinger A, Hofer CK. Platelet function monitoring with the Sonoclot analyzer after in vitro tirofiban and heparin administration. J Thorac Cardiovasc Surg 2006;131:1314-22
21. Horlocker TT, Schroeder DR. Effect of age, gender, and platelet count on Sonoclot coagulation analysis in patients undergoing orthopedic operations. Mayo Clin Proc 1997;72:214-9
22. McKenzie ME, Gurbel PA, Levine DJ, Serebruany VL. Clinical utility of available methods for determining platelet function. Cardiology 1999;92:240-7
23. Ekback G, Carlsson O, Schott U. Sonoclot coagulation analysis: a study of test variability. J Cardiothorac Vasc Anesth 1999;13:393-7
24. Miyashita T, Kuro M. Evaluation of platelet function by Sonoclot analysis compared with other hemostatic variables in cardiac surgery. Anesth Analg 1998;87:1228-33
25. Saleem A, Blifeld C, Saleh SA, Yawn DH, Mace ML, Schwartz M, Crawford ES. Viscoelastic measurement of clot formation: a new test of platelet function. Ann Clin Lab Sci 1983;13:115-24
26. Forestier F, Belisle S, Contant C, Harel F, Janvier G, Hardy JF. [Reproducibility and interchangeability of the Thromboelastograph, Sonoclot and Hemochron activated coagulation time in cardiac surgery]. Can J Anaesth 2001;48:902-10
27. Tuman KJ, Spiess BD, McCarthy RJ, Ivankovich AD. Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass. Anesth Analg 1989;69:69-75
28. Nuttall GA, Oliver WC, Ereth MH, Santrach PJ. Coagulation tests predict bleeding after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997;11:815-23
29. Wang JS, Lin CY, Hung WT, O'Connor MF, Thisted RA, Lee BK, Karp RB, Yang MW. Thromboelastogram fails to predict postoperative hemorrhage in cardiac patients. Ann Thorac Surg 1992;53:435-9
30. Cammerer U, Dietrich W, Rampf T, Braun SL, Richter JA. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003;96:51-7
31. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999;88:312-9
32. Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W. An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfus Med 2006;16:31-9
33. Spalding GJ, Hartrumpf M, Sierig T, Oesberg N, Kirschke CG, Albes JM. Cost reduction of perioperative coagulation management in cardiac surgery: value of 'bedside' thrombelastography (ROTEM). Eur J Cardiothorac Surg 2007;31:1052-7
34. Avidan MS, Alcock EL, Da FJ, Ponte J, Desai JB, Despotis GJ, Hunt BJ. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 2004;92:178-86
35. Miller BE, Guzzetta NA, Tosone SR, Levy JH. Rapid evaluation of coagulopathies after cardiopulmonary bypass in children using modified thromboelastography. Anesth Analg 2000;90:1324-30
36. Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 2001;86:575-8
37. Bull MH, Huse WM, Bull BS. Evaluation of tests used to monitor heparin therapy during extracorporeal circulation. Anesthesiology 1975;43:346-53
38. Despotis GJ, Gravlee G, Filos K, Levy J. Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology 1999;91:1122-51
39. Prisco D, Paniccia R. Point-of-Care Testing of Hemostasis in Cardiac Surgery. Thromb J 2003;1:1
40. Shore-Lesserson L. Monitoring anticoagulation and hemostasis in cardiac surgery. Anesthesiol Clin North Am 2003;21:511-26
41. Chavez JJ, Foley DE, Snider CC, Howell JC, Cohen E, Muenchen RA, Carroll RC. A novel thrombelastograph tissue factor/kaolin assay of activated clotting times for monitoring heparin anticoagulation during cardiopulmonary bypass. Anesth Analg 2004;99:1290-4
42. Kang YG, Martin DJ, Marquez J, Lewis JH, Bontempo FA, Shaw BW Jr, Starzl TE, Winter PM. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1985;64:888-96
43. Gillies BS. Thromboelastography and liver transplantation. Semin Thromb Hemost 1995;21 Suppl 4:45-9
44. Kang Y. Coagulation and liver transplantation. Transplant Proc 1993;25:2001-5
45. Schumann R. Intraoperative resource utilization in anesthesia for liver transplantation in the United States: a survey. Anesth Analg 2003;97:21-8
46. Stahl RL, Duncan A, Hooks MA, Henderson JM, Millikan WJ, Warren WD. A hypercoagulable state follows orthotopic liver transplantation. Hepatology 1990;12:553-8
47. Cerutti E, Stratta C, Romagnoli R, Schellino MM, Skurzak S, Rizzetto M, Tamponi G, Salizzoni M. Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation. Liver Transpl 2004;10:289-94
48. Chapin JW, Becker GL, Hulbert BJ, Newland MC, Cuka DJ, Wood RP, Shaw BW Jr. Comparison of Thromboelastograph and Sonoclot coagulation analyzer for assessing coagulation status during orthotopic liver transplantation. Transplant Proc 1989;21:3539
49. Bindi ML, Biancofiore GD, Consani G, Cellai F, Cecconi N, Romanelli A, Filipponi F, Mosca F, Amorese G, Vagelli A. Blood coagulation monitoring during liver transplantation: Sonoclot analysis and laboratory tests. Minerva Anestesiol 2001;67:359-69
50. Cayley WE Jr. Preventing deep vein thrombosis in hospital inpatients. BMJ 2007;335:147-51
51. McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, nett-Guerrero E. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005;100:1576-83
52. Irish A. Hypercoagulability in renal transplant recipients. Identifying patients at risk of renal allograft thrombosis and evaluating strategies for prevention. Am J Cardiovasc Drugs 2004;4:139-49
53. Arcelus JI, Traverso CI, Caprini JA. Thromboelastography for the assessment of hypercoagulability during general surgery. Semin Thromb Hemost 1995;21(suppl 4):21-6
54. Mahla E, Lang T, Vicenzi MN, Werkgartner G, Maier R, Probst C, Metzler H. Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery. Anesth Analg 2001;92:572-7
55. Schreiber MA, Differding J, Thorborg P, Mayberry JC, Mullins RJ. Hypercoagulability is most prevalent early after injury and in female patients. J Trauma 2005;58:475-80
56. Rugeri L, Levrat A, David JS, Delecroix E, Floccard B, Gros A, Allaouchiche B, Negrier C. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 2007;5:289-95
57. Sorensen B, Ingerslev J. Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography. Haemophilia 2005;11(suppl 1):1- 6
58. Coppell JA, Thalheimer U, Zambruni A, Triantos CK, Riddell AF, Burroughs AK, Perry DJ. The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays. Blood Coagul Fibrinolysis 2006;17:97-104
59. Di NM, Middeldorp S, Buller HR. Direct thrombin inhibitors. N Engl J Med 2005;353:1028-40
60. Nielsen VG, Steenwyk BL, Gurley WQ, Pereira SJ, Lell WA, Kirklin JK. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro. J Heart Lung Transplant 2006;25:653-63
61. Carroll RC, Chavez JJ, Simmons JW, Snider CC, Wortham DC, Bresee SJ, Cohen E. Measurement of patients' bivalirudin plasma levels by a thrombelastograph ecarin clotting time assay: a comparison to a standard activated clotting time. Anesth Analg 2006;102:1316-9
62. Reverter JC, Beguin S, Kessels H, Kumar R, Hemker HC, Coller BS. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis." J Clin Invest 1996;98:863-74
63. Tanaka KA, Katori N, Szlam F, Sato N, Kelly AB, Levy JH. Effects of tirofiban on haemostatic activation in vitro. Br J Anaesth 2004;93:263-9
64. Rand ML, Leung R, Packham MA. Platelet function assays. Transfus Apheresis Sci 2003;28:307-17
65. Harrison P. Platelet function analysis. Blood Rev 2005;19:111-23
66. Craft RM, Chavez JJ, Bresee SJ, Wortham DC, Cohen E, Carroll RC. A novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med 2004;143:301-9
67. Carroll RC, Chavez JJ, Snider CC, Meyer DS, Muenchen RA. Correlation of perioperative platelet function and coagulation tests with bleeding after cardiopulmonary bypass surgery. J Lab Clin Med 2006;147:197-204
68. Bochsen L, Wiinberg B, Kjelgaard-Hansen M, Steinbruchel DA, Johansson PI. Evaluation of the TEG platelet mapping assay in blood donors. Thromb J 2007;5:3
69. Waters JH, Anthony DG, Gottlieb A, Sprung J. Bleeding in a patient receiving platelet aggregation inhibitors. Anesth Analg 2001;93:878-82
70. Spiess BD, Royston D, Levy JH, Fitch J, Dietrich W, Body S, Murkin J, Nadel A. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 2004;44:1143-8
71. Fries D, Krismer A, Klingler A, Streif W, Klima G, Wenzel V, Haas T, Innerhofer P. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br J Anaesth 2005;95:172-7
72. Fries D, Haas T, Klingler A, Streif W, Klima G, Martini J, Wagner-Berger H, Innerhofer P. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy-a porcine model. Br J Anaesth 2006;97:460-7
73. Ganter MT, Schmuck S, Hamiel CR, Zollinger A, Hofer CK. Monitoring the effects of factor VIIa treatment in-vitro after severe hemodilution (part I - Sonoclot). Anesthesiology 2006;105(suppl):A1005
74. Shander A, Goodnough LT, Ratko T, Matuszewski KA, Cohn S, Diringer M, Edmunds H, Lawson J, MacLaren R, Ness P, Shere-Wolfe R, Dubois R. Consensus recommendations for the off-label use of recombinant human factor VIIa (NovoSeven) therapy. Pharmacy & Therapeutics 2005;30:644-58
75. Vincent JL, Rossaint R, Riou B, Ozier Y, Zideman D, Spahn DR. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding-a Eur perspective. Crit Care 2006;10:R120
76. Sorensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003;1:551-8
77. Nielsen VG, Lyerly RT III, Gurley WQ. The effect of dilution on plasma coagulation kinetics determined by thrombelastography is dependent on antithrombin activity and mode of activation. Anesth Analg 2004;99:1587-92
78. Rivard GE, Brummel-Ziedins KE, Mann KG, Fan L, Hofer A, Cohen E. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J Thromb Haemost 2005;3:2039-43
79. Schmuck S, Ganter MT, Hamiel CR, Zollinger A, Hofer CK. Monitoring the effects of factor VIIa treatment in-vitro after severe hemodilution (part II - ROTEM). Anesthesiology 2006;105(suppl):A1001
80. Wettstein P, Haeberli A, Stutz M, Rohner M, Corbetta C, Gabi K, Schnider T, Korte W. Decreased factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intraoperative bleeding. Anesth Analg 2004;99:1564 -9